Health  Vol.6 No.15 , August 2014
Oxygen Therapy in Critical Care: A Double Edged Sword
Abstract: The oxygen therapy is a universal treatment in the hospital setting, especially in the critical care units. The purpose of this therapy is to avoid hypoxemia and to ensure an adequate supply of oxygen to the tissues. But often we overlook the potential adverse effects of oxygen therapy. Oxygen produces lung damage and induces apoptosis and cell death creating an imbalance between the production of reactive species of oxygen and the antioxidant mechanisms. The oxygen therapy inhibits systemic adaptive changes induced by hypoxia, disrupting compensatory mechanisms and causing deleterious effects. We are faced with a challenge in order to treat patients with respiratory failure, counterbalancing hypoxia with hyperoxia-induced damage and introducing therapy lines that are innovative but not risk-free as permissive hypoxemia. Currently many questions remain unresolved and there are not enough clinical studies that validate the therapeutic optimal oxygenation ranges. These ranges may differ depending on each patient and the underlying disease.
Cite this paper: del Portillo, I. , Vázquez, S. , Mendoza, J. and Moreno, R. (2014) Oxygen Therapy in Critical Care: A Double Edged Sword. Health, 6, 2035-2046. doi: 10.4236/health.2014.615238.

[1]   West, J.B. (2007) Pulmonary Pathophysiology: The Essentials. 7th Edition, Lippincott Williams and Wilkins, Philadelphia.

[2]   Campbell, E.J.M. (1965) Respiratory Failure. BMJ, 1, 1451-1460.

[3]   De Lucas, P., Güell, R.R., Rodríguez, J.M. and Antón, A.A. (2007) Tratado de Insuficiencia Respiratoria. Ergón Ltd., Madrid.

[4]   Cabrera Navarro, P. and Rodríguez de Castro, F. (2005) Manual de Enfermedades Respiratorias. 2a Ed. Union Internacional Contra la Tuberculosis y Enfermedades Respiratorias ED, 605-611.

[5]   George, R.B., Light, R.W., Matthay, M.A. and Matthay, R.A. (2005) Chest Medicine: Essentials of Pulmonary and Critical Care Medicine. 5th Edition, Lippincott-Williams and Wilkins, Philadelphia.

[6]   Nunn, J.F. (1993) Diffusion and Alveolar/Capillary Permeability. In: Nunn’s Applied Respiratory Physiology, 4th Editon, Butterworth-Heinemann Ltd, Edinburgh, 198-218.

[7]   Greene, K.E. and Peters, J.I. (1994) Pathophysiology of Acute Respiratory Failure. Clinics in Chest Medicine, 15, 1-12.

[8]   Mackenzie, I. (2008) Core Topics in Mechanical Ventilation. Cambridge University Press, Cambridge, 12-17.

[9]   Carpio, C., Romera, D. and Fernández-Bujarrabal, J. (2010) Insuficiencia Respiratoria Aguda. Medicine, 10, 4332-4338.

[10]   Roussos, C. and Koutsoukou, A. (2003) Respiratory Failure. European Respiratory Journal, 22, 3S-14S.

[11]   Wood, L.D.H. (1998) The Pathophysiology and Differential Diagnosis of Acute Respiratory Failure. In: Hall, J.B., Schmidt, G.A. and Wood, L.D.H., Eds., Principles of Critical Care, McGraw-Hill, New York, 449-508.

[12]   Michiels, C. (2004) Physiological and Pathological Responses to Hypoxia. The American Journal of Pathology, 164, 1875-1882.

[13]   Eltzschig, H.K. and Carmeliet, P. (2011) Hypoxia and Inflammation. The New England Journal of Medicine, 364, 656-665.

[14]   Semenza, G.L. (2011) Oxygen Sensing, Homeostasis and Disease. The New England Journal of Medicine, 365, 537-547.

[15]   Semenza, G.L. (2006) Regulation of Physiological Responses to Continuous and Intermittent Hypoxia by Hypoxia-Inducible Factor 1. Experimental Physiology, 91, 803-806.

[16]   Benizri, E., Ginouvès, A. and Berra, E. (2008) The Magic of the Hypoxia-Signaling Cascade. Cellular and Molecular Life Sciences, 65, 1133-1149.

[17]   Kallet, R.H. and Matthay, M.A. (2013) Hyperoxic Acute Injury Lung. Respiratory Care, 58, 123-141.

[18]   Altemeier, W.A. and Sinclair, S.E. (2007) Hyperoxia in the Intensive Care Unit: Why More Is Not Always Better. Current Opinion in Critical Care, 13, 73-78.

[19]   Horowitz, S. (1999) Pathways to Cell Death in Hyperoxia. Chest, 116, 64S-67S.

[20]   Martin, D.S. and Grocott, M.P.W. (2013) Oxygen Therapy in Critical Illness: Precise Control of Arterial Oxygenation and Permissive Hypoxemia. Critical Care Medicine, 41, 423-432.

[21]   Martin, D.S., Khosravi, M., Grocott, M.P. and Mythen, M.G. (2010) Concepts in Hypoxia Reborn. Critical Care, 14, 315.

[22]   Suzuki, S., Eastwood, G.M., Glassford, N.J., Peck, L., Young, H., Garcia-Alvarez, M., et al. (2014) Conservative Oxygen Therapy in Mechanically Ventilated Patients: A Pilot Before-and-After Trial. Critical Care Medicine, 42, 1414-1422.

[23]   Clark, J.M. and Lambertsen, C.J. (1971) Pulmonary Oxygen Toxicity: A Review. Pharmacological Reviews, 23, 37-133.

[24]   Nash, G., Blennerhassett, J.B. and Pontoppidan, H. (1967) Pulmonary Lesions Associated with Oxygen Therapy and Artificial Ventilation. The New England Journal of Medicine, 276, 368-374.

[25]   Bailey, T.C., Martin, E.L., Zhao, L. and Veldhuizen, R.A. (2003) High Oxygen Concentrations Predispose Mouse Lungs to the Deleterious Effects of High Stretch Ventilation. Journal of Applied Physiology, 94, 975-982.

[26]   Sinclair, S.E., Altemeier, W.A., Matute-Bello, G. and Chi, E.Y. (2004) Augmented Lung Injury Due to Interaction between Hyperoxia and Mechanical Ventilation. Critical Care Medicine, 32, 2496-2501.

[27]   The Acute Respiratory Distress Syndrome Network (2000) Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress Syndrome. The New England Journal of Medicine, 342, 1301-1308.

[28]   O’Driscoll, B.R., Howard, L.S. and Davison, A.G. (2008) BTS Guideline for Emergency Oxygen Use in Adult Patients. Thorax, 63, vi1-vi68.

[29]   Gilbert-Kawai, E.T., Mitchell, K., Martin, D., Carlisle, J. and Grocott, M.P. (2014) Permissive Hypoxaemia versus Normoxaemia for Mechanically Ventilated Critically Ill Patients. Cochrane Database of Systematic Reviews, No. 5.

[30]   Farquhar, H., Weatherall, M., Wijesinghe, M., Perrin, K., Ranchord, A., Simmonds, M. and Beasley, R. (2009) Systematic Review of Studies of the Effect of Hyperoxia on Coronary Blood Flow. American Heart Journal, 158, 371-377.

[31]   Wijesinghe, M., Perrin, K., Ranchon, A., et al. (2009) Routine Use of Oxygen in the Treatment of Myocardial Infarction: Systematic Review. Heart, 95, 198-202.

[32]   Stub, D., Smith, K., Bernard, S., et al. (2012) A Randomized Controlled Trial of Oxygen Therapy in Acute Myocardial Infarction Air Verses Oxygen in Myocardial Infarction Study (AVOID Study). American Heart Journal, 163, 339-345.e1.

[33]   ACCF/AHA Task Force on Practice Guidelines (2013) Manual for ACCF/AHA Guideline Writing Committees: Methodologies and Policies from the ACCF/AHA Task Force on Practice Guidelines. American College of Cardiology and American Heart Association.

[34]   Jauch, E.C., Saver, J.L., Adams Jr., H.P., Bruno, A., Connors, J.J., Demaerschalk, B.M., Khatri, P., McMullan Jr., P.W., Qureshi, A.I., Rosenfield, K., Scott, P.A., Summers, D.R., Wang, D.Z., Wintermark, M., Yonas, H., on Behalf of the American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Peripheral Vascular Disease and Council on Clinical Cardiology (2013) Guidelines for the Early Management of Patients with Acute Ischemic Stroke: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke, 44, 870-947.

[35]   Elley, H., Chiu, H., Liu, C.-S., Tan, T.-Y. and Chang, K.-C. (2006) Venturi Mask Adjuvant Oxygen Therapy in Severe Ischemic Stroke. Archives of Neurology, 63, 741-744.

[36]   Ronning, O.M. and Guldvog, B. (1999) Should Stroke Victims Routinely Receive Supplemental Oxygen? A Quasi-Randomized Controlled Trial. Stroke, 30, 2033-2037.

[37]   Plant, P.K., Owen, J.L. and Elliott, M.W. (2000) One Year Period Prevalence Study of Respiratory Acidosis in Acute Exacerbations of COPD: Implications for the Provision of Non-Invasive Ventilation and Oxygen Administration. Thorax, 55, 550-554.

[38]   Austin, M.A., Wills, K.E., Blizzard, L., Walters, E.H. and Wood-Baker, R. (2010) Effect of High Flow Oxygen on Mortality in Chronic Obstructive Pulmonary Disease Patients in Prehospital Setting: Randomised Controlled Trial. BMJ, 341, c5462.

[39]   Bellomo, R., Bailey, M., Eastwood, G.M., et al. (2011) Arterial Hy-peroxia and In-Hospital Mortality after Resuscitation from Cardiac Arrest. Critical Care, 15, R90.

[40]   Eastwood, G.M., Young, P.J. and Bellomo, R. (2014) The Impact of Oxygen and Carbon Dioxide Management on Outcome after Cardiac Arrest. Current Opinion in Critical Care, 20, 266-272.

[41]   Pryor, K.O., Fahey 3rd, T.J., Lien, C.A. and Goldstein, P.A. (2004) Surgical Site Infection and the Routine Use of Perioperative Hyperoxia in a General Surgical Population: A Randomized Controlled Trial. JAMA, 291, 79-87.

[42]   Greif, R., Akca, O., Horn, E.P., et al., for the Outcomes Research Group (2000) Supplemental Perioperative Oxygen to Reduce the Incidence of Surgical-Wound Infection. The New England Journal of Medicine, 342, 161-167.

[43]   Chang, D. (2014) Clinical Application of Mechanical Ventilation. 4th Edition, Delmar, New York.